{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:23:53Z","timestamp":1720052633581},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1001\/amajethics.2024.520","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:48:47Z","timestamp":1720010927000},"page":"E520-526","source":"Crossref","is-referenced-by-count":0,"title":["When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?"],"prefix":"10.1001","volume":"26","member":"10","published-online":{"date-parts":[[2024,7,1]]},"container-title":["AMA Journal of Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/when-medication-treatment-opioid-use-disorder-gets-disrupted-extra-clinical-variables-how-should\/2024-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T12:48:50Z","timestamp":1720010930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/when-medication-treatment-opioid-use-disorder-gets-disrupted-extra-clinical-variables-how-should\/2024-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":0,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,1]]}},"alternative-id":["10.1001\/amajethics.2024.520"],"URL":"https:\/\/doi.org\/10.1001\/amajethics.2024.520","relation":{},"ISSN":["2376-6980"],"issn-type":[{"value":"2376-6980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}